{"id":2773,"date":"2013-10-08T15:14:28","date_gmt":"2013-10-08T15:14:28","guid":{"rendered":"\/?p=2773"},"modified":"2013-10-08T15:14:37","modified_gmt":"2013-10-08T15:14:37","slug":"applied-dna-sciences-inc-otcmktsapdn-continues-its-descent","status":"publish","type":"post","link":"\/articles\/applied-dna-sciences-inc-otcmktsapdn-continues-its-descent\/","title":{"rendered":"Applied DNA Sciences, Inc. (OTCMKTS:APDN) Continues Its Descent"},"content":{"rendered":"

\"72APDN_chart.png\"Applied DNA Sciences, Inc. (OTCMKTS:APDN<\/a>)’s stock has been descending the charts since mid-May and we rarely see it close in the green. Back then it peaked at $0.264 on May 15 before it started to slide down. The financial report that was filed in August didn’t make things better and the total loss in value that APDN<\/a> has recorded in the period amounts to 65%. <\/p>\n

Most recently APDN<\/a>‘s stock saw some investor interest after the October 2 press release with which the company informed the public that it has signed its fifth original component manufacturer contract, allowing SigNature® DNA marking of parts under the Defence Logistics Agency reguirement.<\/p>\n

The boost in price was little with only 6.32%, but the amount of shares came at a whopping 9.7 million, which was the highest in more than 3 months and helped generate a trade value of 997 thousand dollars.<\/p>\n

\"0512LOGO.png\"After that the stock resumed its downward slide registering a minor gain of 2.06% in Friday’s session. APDN<\/a> opened this week with a loss of 5.05% continuing the path that the company stock has taken. The total amount of shares that switched hands came at 2.8 million and helped generate a trade value of $269.<\/p>\n

The ticker is likely to continue moving the same way in anticipation of the next financial report. Here is a quick reminder of the numbers of prime interest from APDN<\/a>‘s Q2 report for those of you who haven’t followed our coverage on the company.<\/p>\n

 <\/p>\n